Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy

Movement Disorders : Official Journal of the Movement Disorder Society
Hiroshi NagayamaYasuo Katayama

Abstract

[(123)I]-Meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is useful for distinguishing multiple system atrophy (MSA) from Parkinson disease. In this study, longitudinal observation using MIBG myocardial scintigraphy was carried out in patients with MSA to evaluate the association of myocardial MIBG uptake with clinical features. A total of 96 MIBG examinations were performed in 52 patients with MSA. The heart/mediastinum (H/M) ratio of MIBG uptake at 240 minutes after injection was below the lower limit in 16 patients with MSA (31.3%). Overall, the H/M ratio correlated with neither disease duration nor severity. In the follow-up observations, the H/M ratio did not show any specific trends, in contrast with the continuous decrease observed in patients with Parkinson's disease. This data clearly showed that cardiac MIBG uptake cannot necessarily be preserved in patients with MSA and that approximately 30% of patients with MSA showed decreased MIBG uptake without any correlation to disease duration or severity.

References

May 1, 1999·Journal of the Neurological Sciences·S GilmanG K Wenning
Sep 9, 2000·Annals of Internal Medicine·D S GoldsteinR O Cannon
Jun 1, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·H WatanabeG Sobue
Jan 17, 2002·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·S Braune
Jan 30, 2004·Lancet Neurology·Gregor K WenningWerner Poewe
Sep 29, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Gregor K WenningUNKNOWN Multiple System Atrophy Study Group
Jan 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·H NagayamaY Katayama
Nov 8, 2006·Acta Neuropathologica·Satoshi OrimoHitoshi Takahashi
Apr 10, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Hiroshi NagayamaOsamu Mori

❮ Previous
Next ❯

Citations

Apr 16, 2014·Revista española de medicina nuclear e imagen molecular·J ArbizuL Vela
May 29, 2014·Nature Reviews. Neurology·Eduardo E Benarroch
Feb 11, 2015·Journal of Neurology·Han-Joon KimKurt A Jellinger
Apr 22, 2016·Journal of Neural Transmission·Kurt A Jellinger, Gregor K Wenning
Jul 1, 2016·Rinshō shinkeigaku = Clinical neurology·Hirohisa WatanabeGen Sobue
Apr 6, 2017·Current Neurology and Neuroscience Reports·Brice LaurensWassilios G Meissner
Jan 17, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Wassilios G Meissner, Anne Pavy-Le Traon
Oct 7, 2017·Journal of Alzheimer's Disease : JAD·Kurt A Jellinger
Jan 31, 2018·Frontiers in Neurology·Sazuku NisitaniYoji Katsuoka
Oct 13, 2017·Expert Review of Neurotherapeutics·Kurt A Jellinger
Aug 15, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A B DeutschländerZ K Wszolek
Feb 8, 2019·Expert Opinion on Pharmacotherapy·Santiago Pérez-LloretOlivier Rascol
May 18, 2011·Current Opinion in Neurology·Gregor K WenningWerner Poewe
Nov 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Elizabeth A CoonWolfgang Singer
Jun 21, 2014·Current Opinion in Neurology·Philipp T Meyer, Sabine Hellwig
Mar 7, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Jose-Alberto Palma, Horacio Kaufmann
Oct 17, 2018·European Journal of Nuclear Medicine and Molecular Imaging·Iñigo GabilondoJuan Carlos Gómez-Esteban
Aug 13, 2020·Journal of Neural Transmission·Tomohiko NakamuraMasahisa Katsuno
Jan 4, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Elizabeth A CoonEduardo E Benarroch
Sep 22, 2020·Fortschritte der Neurologie-Psychiatrie·Thilo van EimerenCarsten Buhmann
Nov 7, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Wassilios G MeissnerOlivier Rascol
Aug 9, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Matthew R Burns, Nikolaus R McFarland
Jan 22, 2021·Parkinsonism & Related Disorders·Takayasu MishimaYoshio Tsuboi
Dec 15, 2020·NPJ Parkinson's Disease·Joachim BrumbergPhilipp T Meyer
Oct 15, 2020·International Journal of Molecular Sciences·Maria RicciOrazio Schillaci
Mar 17, 2021·Neurobiology of Disease·Joachim BrumbergKathrin Doppler
Mar 31, 2021·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Arthur LoJitendra Kanodia
Sep 6, 2018·Parkinsonism & Related Disorders·Stéphane ThoboisEmmanuel Broussolle
Jul 24, 2021·Movement Disorders Clinical Practice·Mauro CatalanPaolo Manganotti
Apr 22, 2020·Clinical Parkinsonism & Related Disorders·Yusuke TokuharaHiroo Yoshikawa
Jul 14, 2021·Expert Review of Neurotherapeutics·Luca MarsiliCarlo Colosimo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.